vimarsana.com
Home
Live Updates
VACCINE TEAM | Q&A on 'breakthrough cases,' those with needl
VACCINE TEAM | Q&A on 'breakthrough cases,' those with needl
VACCINE TEAM | Q&A on 'breakthrough cases,' those with needle phobia
VACCINE TEAM | Q&A on ‘breakthrough cases,’ those with needle phobia
WKYT News Staff
© Provided by Lexington WKYT
WKYT Vaccine Team Q&A
LEXINGTON, Ky. (WKYT) - As we continue to watch vaccines roll out across Kentucky, we are here to answer your questions.
Are there any statistics on if any new cases of COVID-19 are people who have been vaccinated?
While rare, “breakthrough cases” do happen.
In clinical trials, the approved COVID-19 vaccines were very effective in preventing COVID-19: Moderna, 94.1% effective; Pfizer, 95% effective; and Johnson & Johnson, 66.3% effective. But that’s not 100%.
In December, Kentucky State Auditor Mike Harmon tested positive for the virus shortly after he received his first dose of the vaccine. In a January interview, he said he still believes the vaccine is safe and effective.
Related Keywords
Michigan ,
United States ,
Kentucky ,
Mike Harmon ,
Centers For Disease ,
Pfizer ,
Distribution Work Group ,
Vaccine Team ,
Johnson ,
Kentucky State Auditor Mike Harmon ,
Melanie Swift ,
Mayo Clinic ,
Disease Control ,
மிச்சிகன் ,
ஒன்றுபட்டது மாநிலங்களில் ,
கெந்டகீ ,
மைக் ஹார்மன் ,
மையங்கள் க்கு நோய் ,
ஃபைசர் ,
விநியோகம் வேலை குழு ,
தடுப்பூசி அணி ,
ஜான்சன் ,
கெந்டகீ நிலை தணிக்கையாளர் மைக் ஹார்மன் ,
மெலனி ஸ்விஃப்ட் ,
மயோ சிகிச்சையகம் ,
நோய் கட்டுப்பாடு ,